EV Manufacturing & Testing (MIT collaboration)

This forecast from the Food and Drug Administration outlines dedicated funding for the procurement of specialized isolation kits, reagents, and materials. These resources are intended to support an active and ongoing collaboration with MIT focused on the development of robust manufacturing and testing strategies for Extracellular Vesicles. The project is categorized under NAICS code 325414 and is managed by the FDA. Interested parties can coordinate through the CBER Acquisition Liaison, as the specific contracting officer is yet to be determined.